STAAR Surgical Co
NASDAQ:STAA

Watchlist Manager
STAAR Surgical Co Logo
STAAR Surgical Co
NASDAQ:STAA
Watchlist
Price: 26.68 USD 0.19% Market Closed
Market Cap: 1.3B USD
Have any thoughts about
STAAR Surgical Co?
Write Note

STAAR Surgical Co
Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

STAAR Surgical Co
Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
STAAR Surgical Co
NASDAQ:STAA
Long-Term Debt
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Haemonetics Corp
NYSE:HAE
Long-Term Debt
$1.2B
CAGR 3-Years
20%
CAGR 5-Years
31%
CAGR 10-Years
11%
ICU Medical Inc
NASDAQ:ICUI
Long-Term Debt
$1.5B
CAGR 3-Years
803%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Align Technology Inc
NASDAQ:ALGN
Long-Term Debt
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Lantheus Holdings Inc
NASDAQ:LNTH
Long-Term Debt
$613k
CAGR 3-Years
-85%
CAGR 5-Years
-68%
CAGR 10-Years
-48%
Merit Medical Systems Inc
NASDAQ:MMSI
Long-Term Debt
$750.5m
CAGR 3-Years
40%
CAGR 5-Years
12%
CAGR 10-Years
13%
No Stocks Found

STAAR Surgical Co
Glance View

Market Cap
1.3B USD
Industry
Health Care

STAAR Surgical Co. engages in the development, manufacture, production, marketing, and sale of implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company is headquartered in Lake Forest, California and currently employs 692 full-time employees. The company is a manufacturer of lenses used worldwide in corrective or refractive surgery. The company sells its products in approximately 75 countries, with direct distribution in Japan, Germany, Spain, the United States, Canada, the United Kingdom and Singapore, with a combination of direct distribution and independent distribution in China, Korea, India, France, Benelux and Italy. Its manufacturing facility in Monrovia, California, makes the Visian implantable Collamer lens product family, including the EVO Visian ICL, preloaded silicone cataract intraocular lenses and injector systems. Its manufacturing facility in Brugg, Switzerland, operates an administrative, distribution and operational through its subsidiary, STAAR Surgical AG. The company operates administrative and distribution facilities in Japan through its subsidiary, STAAR Japan Inc.

STAA Intrinsic Value
22.19 USD
Overvaluation 17%
Intrinsic Value
Price

See Also

What is STAAR Surgical Co's Long-Term Debt?
Long-Term Debt
0 USD

Based on the financial report for Sep 27, 2024, STAAR Surgical Co's Long-Term Debt amounts to 0 USD.

Back to Top